Neuroscience
Endocannabinoid System
100%
Antidepressant
100%
Estrogen Receptor
100%
Alzheimer's Disease
60%
Positron Emission Tomography
53%
Treatment-Resistant Depression
50%
Behavioral Effect
50%
Ketamine
50%
Synaptic Vesicle
50%
Astrocyte
50%
Habenula
50%
Beta1 Integrin
50%
Typical Antipsychotic
50%
Bipolar Disorder
50%
Leucine
50%
Atomic Absorption Spectroscopy
50%
Inductively Coupled Plasma Mass Spectrometry
50%
Delusion
50%
Sex Hormone
33%
Major Depressive Disorder
20%
Cannabinoid Receptor Type 1
20%
Transcription Factor FosB
16%
Synapse
13%
Receptor Subtype
11%
Synaptic Plasticity
10%
Neuronal Activity
10%
Synaptogenesis
10%
Cannabinoid 2 Receptor
10%
Midbrain
10%
Depression
10%
Psychiatry
10%
Reward System
10%
Depression
10%
Cannabis
10%
Cannabinoid
10%
Neuroscience
10%
Delusional Disorder
10%
Brain Disease
10%
Neural Network
10%
Parkinson's Disease
10%
Neurotransmitter
8%
Extrapyramidal Symptoms
8%
Hyperglycemia
8%
Dyslipidemia
8%
Adverse Effect
8%
mTOR Signaling
8%
Amnesia
7%
Neurodegenerative Disorder
7%
Memory
7%
Amyloid
7%
Medicine and Dentistry
Pathophysiology
64%
Typical Antipsychotic
50%
Estrogen Receptor
50%
Alzheimer's Disease
50%
Metabolic Syndrome
50%
Leucine
50%
Disease
50%
Patient Compliance
50%
Nosology
50%
Intelligence
50%
Meta-Analysis
50%
Systematic Review
50%
Treatment Response
37%
Subgroup Analysis
25%
Transcription Factor FosB
16%
Quality of Life
15%
Drug Therapy
15%
Combination Therapy
14%
Sex Hormone
14%
Sensitivity and Specificity
12%
Diagnosis
12%
Odds Ratio
12%
Symptomatology
12%
Diagnostic Accuracy
12%
Biological Target
8%
Adverse Event
8%
Finger
8%
Cardiovascular System
8%
Hyperglycemia
8%
mTOR Signaling
8%
Extrapyramidal Symptoms
8%
Dyslipidemia
8%
Climacterium
7%
Amyloid
7%
Lacunar Amnesia
7%
Sex Difference
7%
Glucose Metabolism
7%
Memory
7%
Neurodegenerative Disorder
7%
Pharmacology, Toxicology and Pharmaceutical Science
Endocannabinoid System
50%
Quetiapine
50%
Opiate
50%
Beta1 Integrin
50%
Treatment Resistant Depression
50%
Estrogen Receptor
50%
Bipolar Disorder
50%
Typical Antipsychotic
50%
Metabolic Syndrome X
50%
Alzheimer's Disease
50%
Leucine
50%
Disease
32%
Methadone
31%
Morphine
25%
Pathophysiology
24%
Major Depression
20%
Toxic Injury
18%
Transcription Factor FosB
16%
Pharmacotherapy
15%
Symptom
15%
Sex Hormone
14%
Combination Therapy
14%
Neurotransmitter
12%
Cannabinoid
10%
Remission
10%
Cannabis
10%
Extrapyramidal Symptoms
8%
Adverse Event
8%
Hyperglycemia
8%
Biological Target
8%
Dyslipidemia
8%
Amnesia
7%
Radioligand
7%
4 Aminobutyric Acid
7%
Perimenopause
7%
Amyloid
7%
Antipsychotic
6%
Cannabinoid 2 Receptor
5%
Cannabinoid 2 Receptor Agonist
5%
Emotional Disorder
5%
Clinical Study
5%
